Markers of Intermediate-Term Risk After Heart Transplant - Results of the CTOT-18 Study

J. Stehlik, B. Armstrong, D.A. Baran, A. Chandraker, N.D. Bridges, T. DeMarco, E. Feller, M. Givertz, R. Gordon, P.S. Heeger, A. Heroux, J. Hunt, D.N. Ikle, A.G. Kfoury, J.C. Madsen, Y.R. Morrison, S.P. Pinney, R.C. Starling

The Journal of Heart and Lung Transplantation（2017）

Cited 0|Views38

No score

Abstract

The Clinical Trials in Organ Transplantation (CTOT)-18 study extended the follow-up of the 200 heart transplant recipients enrolled in the CTOT-05 observational, multicenter, cohort for a median of 4.0 yrs (up to 7.2 yrs) after transplant. The aim was to identify clinical, epidemiological and biological markers predictive of adverse clinical events past 1yr.

Translated text

Key words

heart transplant,risk,intermediate-term

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined